UroGen Pharma(URGN) - 2024 Q2 - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2024 Earnings Call August 13, 2024 10:00 AM ET Company Participants Vincent Perrone - Head, Investor Relations Liz Barrett - President and Chief Executive Officer Mark Schoenberg - Chief Medical Officer David Lin - Chief Commercial Officer Dong Kim - Chief Financial Officer Conference Call Participants Tara Bancroft - TD Cowen Raghuram Selvaraju - H.C. Wainwright & Co. Leland Gershell - Oppenheimer Kelsey Goodwin - Guggenheim Securities Matt Kaplan - Ladenburg Thalmann Pa ...